$SENS
Senseonics Holdings, Inc. Stock $sens

$sens Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000155837023014526 Filed on August 10, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$6.097M	$4.126M	$3.714M
YoY Change	31.91%	11.09%	12.92%
Cost Of Revenue	$4.925M	$3.709M	$2.890M
YoY Change	27.39%	28.34%	-0.24%
Gross Profit	$1.200M	$400.0K	$824.0K
YoY Change	58.73%	-51.46%	110.2%
Gross Profit Margin	19.68%	9.69%	22.19%
Selling, General & Admin	$7.425M	$7.455M	$8.561M
YoY Change	1.16%	-12.92%	-6.69%
% of Gross Profit	618.75%	1863.75%	1038.96%
Research & Development	$12.77M	$12.83M	$9.299M
YoY Change	16.24%	37.97%	30.84%
% of Gross Profit	1064.08%	3207.5%	1128.52%
Depreciation & Amortization	$187.0K	$218.0K	$257.0K
YoY Change	-19.05%	-15.18%	-13.18%
% of Gross Profit	15.58%	54.5%	31.19%
Operating Expenses	$20.19M	$20.29M	$17.86M
YoY Change	10.2%	13.58%	9.69%
Operating Profit	-$19.02M	-$19.87M	-$17.04M
YoY Change	8.27%	16.62%	7.21%
Interest Expense	$2.425M	$2.310M	$120.5M
YoY Change	-49.49%	-98.08%	2887.18%
% of Operating Profit
Other Income/Expense, Net	-$5.081M	-$555.0K	-$52.00K
YoY Change	-88.13%	967.31%	-99.97%
Pretax Income	-$24.10M	-$20.42M	$104.2M
YoY Change	-60.09%	-119.59%	-157.81%
Income Tax
% Of Pretax Income
Net Earnings	-$24.10M	-$20.42M	$104.2M
YoY Change	-60.09%	-119.59%	-157.81%
Net Earnings / Revenue	-395.33%	-494.98%	2806.44%
Basic Earnings Per Share	-$0.04	-$0.04	$0.22
Diluted Earnings Per Share	-$0.04	-$0.04	$173.3K
COMMON SHARES
Basic Shares Outstanding	492.9M	479.9M	463.3M
Diluted Shares Outstanding	592.5M	567.1M	601.3M

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$125.4M	$125.1M	$139.2M
YoY Change	-23.09%	-10.14%	-35.27%
Cash & Equivalents	$55.76M	$28.55M	$45.43M
Short-Term Investments	$69.65M	$96.52M	$93.76M
Other Short-Term Assets	$5.546M	$5.708M	$7.499M
YoY Change	3.76%	-23.88%	65.43%
Inventory	$9.726M	$9.194M	$7.251M
Prepaid Expenses
Receivables	$3.450M	$3.675M	$4.044M
Other Receivables	$2.011M	$2.034M	$319.0K
Total Short-Term Assets	$146.1M	$138.2M	$158.3M
YoY Change	-13.68%	-12.68%	-11.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$934.0K	$925.0K	$1.263M
YoY Change	-21.05%	-26.76%	-9.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$7.453M	$11.33M
YoY Change	-100.0%	-34.24%	-78.17%
Other Assets	$1.730M	$1.415M	$4.432M
YoY Change	-48.23%	-68.07%	71.52%
Total Long-Term Assets	$7.925M	$15.13M	$17.03M
YoY Change	-40.75%	-11.13%	-69.53%
TOTAL ASSETS
Total Short-Term Assets	$146.1M	$138.2M	$158.3M
Total Long-Term Assets	$7.925M	$15.13M	$17.03M
Total Assets	$154.1M	$153.4M	$175.3M
YoY Change	-15.66%	-12.53%	-25.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.669M	$975.0K	$1.734M
YoY Change	290.2%	-43.77%	-42.81%
Accrued Expenses	$14.63M	$14.89M	$14.41M
YoY Change	9.85%	3.32%	29.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$14.87M
YoY Change	-100.0%	-100.0%	158.09%
Total Short-Term Liabilities	$17.30M	$15.86M	$31.47M
YoY Change	-69.99%	-49.6%	57.19%
LONG-TERM LIABILITIES
Long-Term Debt	$40.49M	$39.11M	$50.65M
YoY Change	-24.23%	-22.79%	-7.34%
Other Long-Term Liabilities	$6.312M	$6.408M	$77.27M
YoY Change	120.78%	-91.71%	7265.59%
Total Long-Term Liabilities	$6.312M	$6.408M	$127.9M
YoY Change	120.78%	-94.99%	12093.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.30M	$15.86M	$31.47M
Total Long-Term Liabilities	$6.312M	$6.408M	$127.9M
Total Liabilities	$64.34M	$63.17M	$159.4M
YoY Change	-67.46%	-60.37%	-70.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$852.1M	-$828.0M
YoY Change	3.86%
Common Stock	$528.0K	$493.0K
YoY Change	10.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$52.07M	$52.54M	$15.94M
YoY Change
Total Liabilities & Shareholders Equity	$154.1M	$153.4M	$175.3M
YoY Change	-15.66%	-12.53%	-25.43%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$24.10M	-$20.42M	$104.2M
YoY Change	-60.09%	-119.59%	-157.81%
Depreciation, Depletion And Amortization	$187.0K	$218.0K	$257.0K
YoY Change	-19.05%	-15.18%	-13.18%
Cash From Operating Activities	-$17.26M	-$17.98M	-$14.18M
YoY Change	18.38%	26.81%	0.23%
INVESTING ACTIVITIES
Capital Expenditures	$123.0K	$0.00	-$74.00K
YoY Change	-379.55%	-100.0%	105.56%
Acquisitions
YoY Change
Other Investing Activities	$27.77M	-$4.076M	$22.52M
YoY Change	-223.25%	-118.1%	-115.5%
Cash From Investing Activities	$27.65M	-$4.076M	$22.44M
YoY Change	-222.46%	-118.16%	-115.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	16.83M	5.526M	-1.846M
YoY Change	-38.19%	-399.35%	-103.65%
NET CHANGE
Cash From Operating Activities	-17.26M	-17.98M	-14.18M
Cash From Investing Activities	27.65M	-4.076M	22.44M
Cash From Financing Activities	16.83M	5.526M	-1.846M
Net Change In Cash	27.21M	-16.53M	6.414M
YoY Change	-373.69%	-357.78%	-105.89%
FREE CASH FLOW
Cash From Operating Activities	-$17.26M	-$17.98M	-$14.18M
Capital Expenditures	$123.0K	$0.00	-$74.00K
Free Cash Flow	-$17.39M	-$17.98M	-$14.11M
YoY Change	19.58%	27.47%	-0.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Central Index Key EntityCentralIndexKey	0001616543
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	479637138
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	492826683
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20230630#DepositsAndOtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20230630#DepositsAndOtherAssetsNoncurrent
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20230630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20230630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37717
	dei	Entity Registrant Name EntityRegistrantName	Senseonics Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1210911
	dei	Entity Address Address Line1 EntityAddressAddressLine1	20451 Seneca Meadows Parkway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876-7005
	dei	City Area Code CityAreaCode	301
	dei	Local Phone Number LocalPhoneNumber	515-7260
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	SENS
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	492900981
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28551000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35793000
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	89067000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	108222000
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	655000
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	127000
CY2023Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	3020000
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2324000
CY2023Q2	us-gaap	Inventory Net InventoryNet	9194000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7306000
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7742000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7428000
CY2023Q2	us-gaap	Assets Current AssetsCurrent	138229000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	161200000
CY2023Q2	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	6755000
CY2022Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3108000
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	7453000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	12253000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	925000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1112000
CY2023Q2	us-gaap	Assets Assets	153362000
CY2022Q4	us-gaap	Assets Assets	177673000
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	975000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	419000
CY2023Q2	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	14256000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	14616000
CY2023Q2	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	630000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	837000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	15579000
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	20000
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	15861000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31471000
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	39108000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	56383000
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1792000
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	52050000
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6408000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2689000
CY2023Q2	us-gaap	Liabilities Liabilities	63169000
CY2022Q4	us-gaap	Liabilities Liabilities	142593000
CY2023Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	12000
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	12000
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12000
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12000
CY2023Q2	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	37656000
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	37656000
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	37656000
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	37656000
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	492826683
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	479637138
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	493000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	480000
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	880129000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	806488000
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-120000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-678000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-827965000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-808866000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	52537000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2576000
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	153362000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	177673000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	437000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	137000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	750000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	429000
CY2023Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3689000
CY2022Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3577000
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	7513000
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	5767000
CY2023Q2	us-gaap	Revenues Revenues	4126000
CY2022Q2	us-gaap	Revenues Revenues	3714000
	us-gaap	Revenues Revenues	8263000
	us-gaap	Revenues Revenues	6196000
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3709000
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2890000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7433000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4845000
CY2023Q2	us-gaap	Gross Profit GrossProfit	417000
CY2022Q2	us-gaap	Gross Profit GrossProfit	824000
	us-gaap	Gross Profit GrossProfit	830000
	us-gaap	Gross Profit GrossProfit	1351000
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12830000
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9299000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25235000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17103000
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7455000
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8561000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15173000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16445000
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-19868000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-17036000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-39578000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-32197000
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1311000
CY2022Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	241000
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2420000
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	334000
CY2022Q2	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	28224000
	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	49925000
	sens	Nonoperating Gain Loss Exchanges NonoperatingGainLossExchanges	18776000
CY2023Q2	us-gaap	Interest Expense InterestExpense	2310000
CY2022Q2	us-gaap	Interest Expense InterestExpense	4510000
	us-gaap	Interest Expense InterestExpense	6962000
	us-gaap	Interest Expense InterestExpense	9005000
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	289000
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	96548000
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	6067000
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	181117000
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-816000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-846000
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	155000
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-52000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	178000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-71000
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-555000
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	121267000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20479000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	223146000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20423000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	104231000
	us-gaap	Net Income Loss NetIncomeLoss	-19099000
	us-gaap	Net Income Loss NetIncomeLoss	190949000
CY2023Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	100000
CY2022Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-291000
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	558000
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-916000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	100000
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-291000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	558000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-916000
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20323000
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	103940000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18541000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	190033000
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	567125022
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	464133903
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	532499776
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	460061022
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	567125022
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	601330959
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	532499776
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	604342540
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-89469000
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	68000
CY2022Q2	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	1000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2585000
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1184000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	104231000
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-291000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	15941000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-185535000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8004000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	239000
	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	63000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4321000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1184000
	us-gaap	Net Income Loss NetIncomeLoss	190949000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-916000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	15941000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	64464000
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7376000
CY2023Q2	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	2000
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
CY2023Q2	sens	Adjustments To Additional Paid In Capital Warrants Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedIssuanceCosts	260000
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2870000
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1598000
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20423000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	52537000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2576000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7376000
	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	87000
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	63282000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4651000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1603000
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-142000
	us-gaap	Net Income Loss NetIncomeLoss	-19099000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	558000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	52537000
	us-gaap	Profit Loss ProfitLoss	-19099000
	us-gaap	Profit Loss ProfitLoss	190949000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	454000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	520000
	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	3426000
	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	5726000
	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-6067000
	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-181117000
	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	49925000
	sens	Nonoperating Gain Loss Exchanges NonoperatingGainLossExchanges	18776000
	sens	Impairment Of Options ImpairmentOfOptions	846000
	us-gaap	Share Based Compensation ShareBasedCompensation	4651000
	us-gaap	Share Based Compensation ShareBasedCompensation	4321000
	us-gaap	Inventory Write Down InventoryWriteDown	-65000
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	55000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1224000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2070000
	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	314000
	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	1600000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1823000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	934000
	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	26000
	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	-163000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	556000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	530000
	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	493000
	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	44000
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	357000
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-102000
	sens	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-430000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37832000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34341000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	57000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	211000
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	61818000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	87746000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	42319000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25871000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	42108000
	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	7376000
	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	8004000
	sens	Proceeds From Issuance Of Stock Options ProceedsFromIssuanceOfStockOptions	-52000
	sens	Proceeds From Issuance Of Stock Options ProceedsFromIssuanceOfStockOptions	302000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15700000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1603000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1183000
	sens	Proceeds From Issuance Of Warrants Net ProceedsFromIssuanceOfWarrantsNet	14698000
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2926000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4719000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4197000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7242000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11964000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35793000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33461000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28551000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45425000
	us-gaap	Interest Paid Net InterestPaidNet	1756000
	us-gaap	Interest Paid Net InterestPaidNet	3381000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3831000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2944000
	sens	Issuance Of Warrant In Exchange For Phc Notes IssuanceOfWarrantInExchangeForPhcNotes	48564000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7003387
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1357430
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3463862
CY2022	us-gaap	Gross Profit GrossProfit	2700000
CY2021	us-gaap	Gross Profit GrossProfit	-800000
CY2020	us-gaap	Gross Profit GrossProfit	-17400000
CY2023Q2	us-gaap	Gross Profit GrossProfit	400000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-828000000.0
CY2023Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	125100000
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	15000000.0
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, fair value of investments, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, bad debts, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2023Q2	us-gaap	Revenues Revenues	4126000
CY2023Q2	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
	us-gaap	Revenues Revenues	8263000
	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2022Q2	us-gaap	Revenues Revenues	3714000
CY2022Q2	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
	us-gaap	Revenues Revenues	6196000
	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	900000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1700000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20423000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	104231000
	us-gaap	Net Income Loss NetIncomeLoss	-19099000
	us-gaap	Net Income Loss NetIncomeLoss	190949000
CY2022Q2	us-gaap	Dilutive Securities DilutiveSecurities	-124010000
	us-gaap	Dilutive Securities DilutiveSecurities	-228614000
CY2023Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-20423000
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-19779000
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-19099000
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-37665000
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	567125022
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	464133903
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	532499776
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	460061022
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4649548
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	567125022
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	601330959
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	532499776
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	604342540
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	102274485
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34331656
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	102274485
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34563924
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	96640000
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	123000
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	96520000
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	121153000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	678000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	120475000
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	62529000
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	62519000
CY2023Q2	sens	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year Two DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearTwo	27362000
CY2023Q2	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo	27277000
CY2023Q2	sens	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year Three DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearThree	6749000
CY2023Q2	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearThree	6724000
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	96640000
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	96520000
CY2023Q2	sens	Unsettled Stock Issuance Proceeds UnsettledStockIssuanceProceeds	369000
CY2023Q2	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	255000
CY2022Q4	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	924000
CY2023Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	241000
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	336000
CY2023Q2	us-gaap	Prepaid Rent PrepaidRent	150000
CY2023Q2	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	4026000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000
CY2022Q4	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	4097000
CY2023Q2	sens	Tax Credits Receivable TaxCreditsReceivable	1793000
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	625000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1243000
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2379000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1697000
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5408000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4057000
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1407000
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1552000
CY2023Q2	us-gaap	Inventory Net InventoryNet	9194000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7306000
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	132000
CY2023Q2	sens	Prepaid Accounting And Audit PrepaidAccountingAndAudit	48000
CY2022Q4	sens	Prepaid Accounting And Audit PrepaidAccountingAndAudit	270000
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	235000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	426000
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7742000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7428000
CY2023Q2	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	5367000
CY2022Q4	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	3502000
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2558000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4699000
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2381000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1053000
CY2023Q2	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	2105000
CY2022Q4	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	2480000
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1232000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2050000
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	494000
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	781000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	725000
CY2023Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	266000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	149000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14000
CY2023Q2	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	14886000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	15453000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	400000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5340000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3032000
CY2023Q2	sens	Tenant Improvement Allowance Receivable TenantImprovementAllowanceReceivable	1312000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	725000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6408000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2689000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6891000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3414000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	594000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	912000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	939000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	967000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	996000
CY2023Q2	sens	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	5934000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10342000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3451000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6891000
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085
	sens	Product Warranty Term ProductWarrantyTerm	P1Y
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	500000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	800000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	781000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	723000
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	62000
CY2022	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	166000
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	349000
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	108000
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	494000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	781000
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2113000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4708000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	141000
	us-gaap	Interest Expense Debt InterestExpenseDebt	6962000
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3279000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5545000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	181000
	us-gaap	Interest Expense Debt InterestExpenseDebt	9005000
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	51199000
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	51199000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0

Files In Submission

Name	View Source	Status
0001558370-23-014526-index-headers.html	Edgar Link	pending
0001558370-23-014526-index.html	Edgar Link	pending
0001558370-23-014526.txt	Edgar Link	pending
0001558370-23-014526-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sens-20230630.xsd	Edgar Link	pending
sens-20230630x10q.htm	Edgar Link	pending
sens-20230630xex10d1.htm	Edgar Link	pending
sens-20230630xex31d1.htm	Edgar Link	pending
sens-20230630xex31d2.htm	Edgar Link	pending
sens-20230630xex32d1.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sens-20230630_def.xml	Edgar Link	unprocessable
sens-20230630_lab.xml	Edgar Link	unprocessable
sens-20230630_pre.xml	Edgar Link	unprocessable
sens-20230630x10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sens-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SENS
Senseonics Holdings, Inc. Stock $sens

2023 Q3 Form 10-Q Financial Statement

#000155837023014526 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS Senseonics Holdings, Inc. Stock $sens

2023 Q3 Form 10-Q Financial Statement

#000155837023014526 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS
Senseonics Holdings, Inc. Stock $sens